-
Mashup Score: 37CSWG Global Summit 2025 - 8 day(s) ago
Join the Cardiogenic Shock Working Group for its third Global Summit—a free, fully virtual 5-hour event on Wednesday, June 4, 2025, focused on improving patient outcomes in cardiogenic shock. This summit promotes scientific investigation and the generation of real-world evidence through both retrospective and prospective clinical studies, addressing one of the deadliest heart conditions.
Source: www.cardiogenicshocksummit.orgCategories: General Medicine NewsTweet
-
Mashup Score: 33
Cardiogenic shock (CS) is a complex hemodynamic syndrome resulting from reduced cardiac output, and with inordinately high mortality, 50% or more, despite meaningful advances in treatment.1 Use of tMCS, including veno-arterial extracorporeal membrane oxygenation with and without addition of a microaxial flow pump (mAFP) or Impella device, has increased substantially over the last decade, likely due to advances in device technology.2 In the current issue of the Journal, Ott et al. shed more light on the impact of complications on CS mortality in patients treated with tMCS stratified by device type used.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet-
Emerging evidence highlights complications of tMCS use in CS & their impact on ☠️. There's an urgent need for best practices & innovation in tMCS. Read our editorial comment on improving CS outcomes with a focus on ⬇️ complications. @DrClaudiusMahr https://t.co/YyWIhAMi40
-
-
Mashup Score: 3cDPP3 in Cardiogenic Shock: More than just a prognostic marker? - 5 month(s) ago
Dr. Singh, Godding and Kataria report no disclosures. Dr. Kochar reports the following disclosures: Prior funding and site PI – Duke Institute of Health Innovation (DIHI), Duke Clinical Research Institute (DCRI), Abiomed, Novartis, Duke University, LiveNova, Endovascular Engineering, Chiesi; Active Grant Funding – AHA Career Development Award, Shockwave Inc, and Rampart Inc, PCORI; Consultant fees/Honoraria – Abiomed, Faraday Pharmaceuticals.
Source: onlinejcf.comCategories: General Medicine News, CardiologistsTweet-
Could cDPP3 prove to be more than just a prognostic marker in cardiogenic shock? @Ajar_Kochar @AvinainderSingh https://t.co/g6doeZ7NWs
-
-
Mashup Score: 20
Despite dramatic advances in therapeutics for patients with heart failure, fewer trainees are applying to Advanced Heart Failure/Transplant Cardiology (AHFTC) fellowship programs.1 The reasons for this waning interest are likely multifactorial.2 The purpose of this study was to comprehensively review the literature from all medical and surgical specialties, focusing on motivating factors that guide advanced training selection, reasoning that there may be commonalities identified that are applicable to AHFTC fellowship.
Source: onlinejcf.comCategories: General Medicine News, CardiologistsTweet-
Congratulations, @EdanZitelny!! Presenting the novel ExCiTe approach aimed at improving recruitment of trainees into AHFTC Grateful for contributions from co-authors @MarkDrazner @JonathanDavisHF @EMDeFilippisMD @noshreza @KhazanieHeart @jteerlinkmd https://t.co/RIUSuyaclR
-
-
Mashup Score: 3Home | Society of Critical Care Cardiology - 6 month(s) ago
At SoCCC our mission is to improve the care and outcomes of critically ill patients with cardiovascular disease and to promote, uphold, and advance the discipline of Critical Care Cardiology through education, advocacy, scientific discovery, and collaboration
Source: www.soccc.orgCategories: General Medicine News, CardiologistsTweet-
RT @Ajar_Kochar: Interested in Critical Care Cardiology -- join @SocietyOfCCC -- https://t.co/cFg2OY24SJ. @Allison_Dupont @shelleyhallmd @r…
-
-
Mashup Score: 3Home | Society of Critical Care Cardiology - 6 month(s) ago
At SoCCC our mission is to improve the care and outcomes of critically ill patients with cardiovascular disease and to promote, uphold, and advance the discipline of Critical Care Cardiology through education, advocacy, scientific discovery, and collaboration
Source: www.soccc.orgCategories: General Medicine News, CardiologistsTweet-
RT @Ajar_Kochar: Interested in Critical Care Cardiology -- join @SocietyOfCCC -- https://t.co/cFg2OY24SJ. @Allison_Dupont @shelleyhallmd @r…
-
-
Mashup Score: 3Home | Society of Critical Care Cardiology - 6 month(s) ago
At SoCCC our mission is to improve the care and outcomes of critically ill patients with cardiovascular disease and to promote, uphold, and advance the discipline of Critical Care Cardiology through education, advocacy, scientific discovery, and collaboration
Source: www.soccc.orgCategories: General Medicine News, CardiologistsTweet-
RT @Ajar_Kochar: Interested in Critical Care Cardiology -- join @SocietyOfCCC -- https://t.co/cFg2OY24SJ. @Allison_Dupont @shelleyhallmd @r…
-
-
Mashup Score: 27TecSalud | Cardiogenic Shock & Heart Failure Symposium - 8 month(s) ago
Octubre 02 & 03 2024 CANCÚN, MÉXICO El Segundo Simposio Anual de Shock Cardiogénico e Insuficiencia Cardíaca es un evento de primer nivel liderado por TecSalud, centrado en los avances, desafíos y enfoques innovadores en el manejo del shock cardiogénico y la insuficiencia cardíaca aguda. El tema de este año Creando equipos de “shock” ¿Qué se necesita para implementar un equipo? El choque cardiogénico es un problema clínico complejo y con alta mortalidad. Se ha publicado que la creación de “shock teams”
Source: content.tecsalud.mxCategories: General Medicine News, CardiologistsTweet-
Excited for ShOC(K)TOBER starting with @TecSaludMX's Cardiogenic Shock & Heart Failure symposium followed by @SCAI Shock 2024! Look forward to learning about management of CS across various practice settings https://t.co/KQ69tQkjro https://t.co/FHJerBqaXA @JHMontfort10 https://t.co/fmPfryEDJo
-
-
Mashup Score: 30Booster Shots: 019 - GDMT w/ Dr. Davis pt. 1 (B-blockers, ARNI) - 1 year(s) ago
We talk to Cardiologist Dr. Jonathan Davis, Director of the Heart Failure program from San Francisco General about goal directed medical therapy in heart failure with reduced ejection fraction (HFrEF). This is part 1 of 2 parts which will cover an overview of GDMT medications, and dive into Beta-blockers and ARNIs. Part 2 to come out next week! | 00.34 – Introduction | | 01.55 – Consult Q: GDMT for HF | Heart failure outcomes | 05.20 – GDMT medication summary and overview | | 07.17 – Effect on blood pressure and relative risk reduction for each drug | | 10.59 – What order to start in | Hint: ALL AT ONCE… if you can | 11.53 – Beta-blockers | When not to start (new HF in VOL), and when to re/start (almost all other times) Tartrate vs Succinate: duration of action | 15.40 – ARNI (Sacubitril-Valsartan) | Potent natriuresis effect Balancing the orthostatics | 20.37 – Outro | [The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the inform
Source: sites.libsyn.comCategories: General Medicine News, CardiologistsTweet-
Listen to this podcast on #GDMT and inpatient mgmt of HF, with the master educator - Dr. @JonathanDavisHF!! Part 1 of 2 - BBs and ARNi 🎧 https://t.co/GYubs8pjgK @AHajduczok @SantosGallegoMD @docbhardwaj @MarkBelkinMD @LAuroraMD @hvanspall @DrRaniKhatib @RyanTedfordMD https://t.co/joKvAGZ4HT
-
-
Mashup Score: 17Submit Your Science | Houston Shock - 1 year(s) ago
The Houston Shock Symposium is one of the largest and most comprehensive shock conferences in the nation. Join us in the heart of Houston, TX to advance knowledge and expertise to save lives and reduce shock’s unacceptably high mortality rate.
Source: www.houstonshock.orgCategories: General Medicine News, CardiologistsTweet-
RT @JumeanMarwan: Submit your science today @ the Sixth Annual Houston Shock Symposium! https://t.co/z0L9b0enm7 https://t.co/dbYxT5Pggx
-
*JOIN US* Wed, June 4 from 2–7:30 pm ET for the 3rd CSWG Global Summit—featuring real-world cases, lightning talks, debates & panels. This global, virtual event is FREE to attend. Registration is open at https://t.co/gXOX1EbvcV #CSWG #CSWG25